Press Releases :: ProMIS Neurosciences, Inc. (PMN)

Feb 6, 2020

ProMIS Neurosciences to Participate in the BIO CEO & Investor Conference

Jan 29, 2020

ProMIS Neurosciences Data for Alzheimer’s Disease Program Targeting Tau Accepted for Presentation at Tau2020

Jan 15, 2020

ProMIS Neurosciences Appoints Dr. José Luis Molinuevo to its Scientific Advisory Board

Jan 9, 2020

ProMIS Neurosciences to present at Sachs 3rd Annual Neuroscience Innovation Forum

Jan 8, 2020

ProMIS Neurosciences issues Chairman’s Update detailing positive outlook for Alzheimer’s disease therapy, pipeline in 2020

Dec 31, 2019

ProMIS Neurosciences Completes Second Closing of Private Placement

Dec 10, 2019

ProMIS Neurosciences’ Alzheimer’s disease program takes on renewed significance following positive aducanumab news

Dec 5, 2019

Aducanumab is good; next generation Alzheimer’s disease therapies will be better

Nov 18, 2019

ProMIS Neurosciences Completes First Closing of Private Placement

Nov 14, 2019

ProMIS Neurosciences Announces Third Quarter 2019 Results